Lenalidomide 15 mg, commonly referred to by its brand name Revlimid, is a medication used primarily in the treatment of multiple myeloma, a type of cancer that affects plasma cells, and certain types of myelodysplastic syndromes. Here’s an overview of its key points:

Uses

• Multiple Myeloma: Often used in combination with other treatments.
• Myelodysplastic Syndromes: Particularly in cases associated with deletion of chromosome 5q.
• Other Cancers: Sometimes used in clinical trials for other hematologic malignancies.

Mechanism of Action

• Lenalidomide works by modulating the immune system and has anti-inflammatory and anti-angiogenic properties. It also promotes apoptosis (programmed cell death) in cancer cells.

Dosage

• The typical starting dose for multiple myeloma is often 10 mg to 25 mg per day, depending on the treatment regimen and patient factors.
• 15 mg is a common dose used in various treatment schedules.

Side Effects

Common side effects may include:

• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Fatigue
• Diarrhea
• Constipation
• Nausea
• Rash
• Increased risk of blood clots

Precautions

• Patients must be monitored regularly for blood counts and potential side effects.
• Women of childbearing potential must use effective contraception during treatment and for a period afterward due to potential teratogenic effects.

Availability

• Lenalidomide is usually available by prescription, and it’s essential to follow a healthcare provider’s guidance regarding its use.

If you need specific information regarding Lenalidomide for your business or for any other purpose, feel free to ask!